Livzon Pharmaceutical completes A share buyback program

Livzon Pharmaceutical Group completed a share repurchase of 163,414 A shares on November 6, 2025, conducted through other securities exchanges. The shares were bought at prices ranging from RMB 36.61 to RMB 36.77 per share, totaling RMB 5,997,099.8. All repurchased shares are intended for cancellation.

This recent buyback contributes to a series of A share repurchases disclosed, covering dates from December 25, 2024, to November 6, 2025. Over this period, the company executed numerous repurchases with varying volumes and prices.

The company confirmed that the repurchases comply with relevant listing rules and were duly authorized by the board. The total number of A shares in issue as of November 6, 2025, remained at 604,293,313, with no change in the number of H shares, which stood at 299,807,117.